Latest News in the pharma Industry

All

Novartis receives EU approval for Cosentyx label update

Novartis receives EU approval for Cosentyx label update

6 Jul 2017

Label update includes 52 week data from CLEAR study demonstrating long-term superiority of Cosentyx versus Stelara in psoriasis.

Read more 
Specialist CRO expands pharmacovigilance capabilities

Specialist CRO expands pharmacovigilance capabilities

6 Jul 2017

Pharma clients now have direct and immediate access to a fully compliant safety database without needing to invest in their own system or use an interim solution to ensure compliance.

Read more 
Phase III study evaluating safety and efficacy of adjuvant Opdivo in resected melanoma patients meets primary endpoint

Phase III study evaluating safety and efficacy of adjuvant Opdivo in resected melanoma patients meets primary endpoint

6 Jul 2017

Opdivo demonstrates superior recurrence-free survival versus Yervoy in adjuvant setting in CheckMate -238.

Read more 
New design for nutrients - Doppelherz sparkles with effervescent IML packaging from Sanner

New design for nutrients - Doppelherz sparkles with effervescent IML packaging from Sanner

5 Jul 2017

Brilliance tubes provide a user-friendly and attractive all-in-one solution.

Read more 
BIOCAD’s rituximab biosimilar to receive MA in India

BIOCAD’s rituximab biosimilar to receive MA in India

4 Jul 2017

First shipment of BIOCAD’s Acellbia to India is scheduled for September 2017.

Read more 
First patients treated in Phase I/II trial of  NOX-A12 combined with Keytruda in metastatic pancreatic and colorectal cancer

First patients treated in Phase I/II trial of NOX-A12 combined with Keytruda in metastatic pancreatic and colorectal cancer

4 Jul 2017

NOX-A12 has the potential to transform cancer types that are resistant to checkpoint inhibitor therapy into checkpoint inhibitor sensitive tumours

Read more 
Sun Pharma & Samsung BioLogics announce strategic manufacturing tie-up for Tildrakizumab

Sun Pharma & Samsung BioLogics announce strategic manufacturing tie-up for Tildrakizumab

4 Jul 2017

Tildrakizumab is an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe plaque psoriasis.

Read more 
Idifarma approved for EU-GMP commercial capsule manufacturing

Idifarma approved for EU-GMP commercial capsule manufacturing

3 Jul 2017

Idifarma, a Spanish CDMO, has expanded its GMP manufacturing offering with the installation of new automatic capsule filling capabilities at its EU-GMP approved plant in Pamplona, Spain.

Read more 
Common antimicrobials help patients recover from MRSA abscesses

Common antimicrobials help patients recover from MRSA abscesses

3 Jul 2017

NIAID-funded trial counters current thinking about treatment effectiveness.

Read more 
Lilly's Olumiant gets the thumbs up in Japan for the treatment of rheumatoid arthritis

Lilly's Olumiant gets the thumbs up in Japan for the treatment of rheumatoid arthritis

3 Jul 2017

In clinical studies, baricitinib has demonstrated significant improvement in the signs and symptoms of RA compared to standard-of-care therapies.

Read more 
New second generation solvent evaporators from Biotage

New second generation solvent evaporators from Biotage

3 Jul 2017

Three new TurboVap evaporation systems increase laboratory reliability.

Read more 
FDA approves Vectibix for use in wild-type RAS metastatic colorectal cancer

FDA approves Vectibix for use in wild-type RAS metastatic colorectal cancer

2 Jul 2017

First-and-only fully human monoclonal anti-epidermal growth factor receptor antibody approved by the FDA for this patient population.

Read more